DURATION
8–12 weeks
PEPTIDES
2–3
PRIMARY GOAL
Skin Rejuvenation
INJECTIONS / DAY
1–2
GHK-Cu directly stimulates fibroblasts to produce type I and III collagen, elastin, and glycosaminoglycans, the structural proteins of youthful skin.
BPC-157 powerfully reduces inflammatory cytokines in skin tissue. Accelerates healing, reduces redness, calms rosacea and acne scarring.
BPC-157 promotes new blood vessel formation, improving blood supply to skin tissue and accelerating nutrient delivery and waste removal.
GHK-Cu activates matrix metalloproteinases that remove old, cross-linked collagen and replace it with fresh fibers, key to reducing scars and deep wrinkles.
Both compounds in the base stack are stocked locally. Our partner and supplier lists GHK-Cu 50mg at PHP 1,325 and BPC-157 20mg at PHP 2,650, with the standing 10% off at PHP 1,190 and PHP 2,390. Buy GHK-Cu in the Philippines
Phase 01: Loading (Weeks 1–4)
| Peptide | Dose | Frequency | Notes |
|---|---|---|---|
| GHK-Cu Injectable | 2–5mg | Daily or every other day | Subcutaneous near target areas (face, scalp) |
| BPC-157 | 250–500mcg | Daily | Subcutaneous: systemic or local |
Phase 02: Maintenance (Week 5+)
| Peptide | Dose | Frequency | Notes |
|---|---|---|---|
| GHK-Cu Injectable | 2mg | 3× per week | Reduce frequency as skin improves |
| BPC-157 | 250mcg | 3× per week | Maintenance phase |
| GHK-Cu Topical | 0.5–1% | Twice daily (all phases) | Apply morning and evening |
For users targeting wound healing, scarring, or systemic skin issues, adding TB-500 (Thymosin Beta-4) accelerates results. TB-500 promotes actin polymerization in cells, critical for tissue repair and wound healing.
DOSE
500mcg–2mg
FREQUENCY
2× weekly
DURATION
4–8 weeks
ROUTE
Subcutaneous
| Period | Expected Effect |
|---|---|
| Week 1–2 | BPC-157 begins reducing skin inflammation. Subtle brightness in tone. |
| Week 3–4 | GHK-Cu collagen stimulation apparent. Skin firmer, hydrated. Fine lines soften. |
| Week 5–8 | Most visible improvements. Scars flatten, wrinkles reduce, tone evens. |
| Week 9–12 | Consolidation. Transition to maintenance. New collagen matures. |
If the reading is done and the next step is a plan rather than another article, you can build a protocol around your goal at Longevity Manila, which hands off to our partner and supplier, Primara Labs.
Manila skin reality
Manila is a hard environment for skin. Year-round 30–34°C heat, humidity above 70 percent, UV index hitting 11+ at solar noon for most of the year, particulate pollution from EDSA traffic: the protocol above gets you to the starting line; the operational layer is what determines whether the eight-week before/after photos actually show what they should. Sun protection (T-03 in the tips above) is not a generic recommendation here. It is the limiting factor on results.
On the dermatology pairing: the eight-to-twelve-week window of the Glow protocol overlaps perfectly with Manila's established medical-aesthetic ecosystem. Belo Medical Group, The Aivee Institute, and the dermatology clinics at Makati Medical Center, St. Luke's BGC, and Asian Hospital all run combination protocols where peptide injections sit alongside microneedling, fractional laser, or PRP. The clinic-grade work accelerates the dermal turnover the GHK-Cu and BPC-157 are stimulating biochemically. Pricing for a six-session microneedling course in Makati or BGC runs roughly USD 800 to 1,200, fraction of US clinic pricing for the same equipment.
On sourcing: GHK-Cu injectable, BPC-157, and TB-500 are not FDA Philippines registered and live in research-grade territory. Topical GHK-Cu serum at 0.5–1% is sold in Mercury Drug and Watsons under cosmetic-grade labels (the percentage is rarely verified, most local cosmetic GHK-Cu serums are well under 0.5%). For actual protocol-grade topical concentration, source from a research-peptide supplier or a Makati compounding pharmacy. SPF: every Filipino dermatologist I've spoken to recommends a Korean or Japanese tinted sunscreen at SPF 50+ over the typical US chemical sunscreens: Anessa, Biore UV Aqua Rich, Beauty of Joseon. Mercury Drug stocks all three.
January through April 2026
I ran the loading + maintenance schedule from January 8, 2026 through April 2, 2026 (twelve weeks). GHK-Cu injectable 3mg subQ near the temples and forehead five days a week for the first four weeks, BPC-157 250mcg subQ in the abdomen daily for the same window. Topical GHK-Cu serum at roughly 0.8% concentration applied morning and evening (sourced from a compounding pharmacy in Salcedo Village in Makati for USD 38 per 30mL bottle. Mercury Drug stocks 0.5% serums but the labeling is unverified).
Photos at week 0, week 4, week 8, week 12: same lighting, same condo bathroom in BGC, same time of day. By week 4 the redness from a decade of late-twenties Texas sun damage had visibly calmed. By week 8 a horizontal forehead line that had been deepening for two years had softened (not gone, softened). By week 12 the under-eye area was the most-changed region: less hollow, less dark. My partner noticed at week 6 unprompted, which I count as the legitimate signal.
One operational lesson: I underestimated the SPF requirement. Week 5 I spent a Saturday at the beach in Batangas without reapplying my sunscreen properly, came home with a mild burn across the cheekbones. Skin texture in that zone regressed by what I'd guess was two weeks of progress. I switched to Anessa SPF 50+ from the Mercury Drug at SM Aura the next week and didn't make that mistake again. UV is the ceiling on this protocol in PH. Full stop.
What this protocol doesn't replace
This is editorial commentary, not medical advice. GHK-Cu, BPC-157, and TB-500 are not FDA Philippines registered for cosmetic or therapeutic use. They live in research-grade territory and personal use is undertaken at your own risk.
Documented risks: GHK-Cu can cause local injection-site reactions (redness, mild swelling, occasional bruising). BPC-157 is generally well-tolerated in the published preclinical record but human pharmacovigilance data is limited. TB-500 has been associated theoretically with concerns around angiogenesis in the context of existing malignancy. The evidence is weak but it's the reason the World Anti-Doping Agency banned it for athletes.
Do not run this protocol if you have an active malignancy, are pregnant or breastfeeding, have an active infection at the injection site, or have known allergies to copper compounds. If you have a personal or family history of melanoma, consult dermatology before starting GHK-Cu. Get baseline bloodwork (CBC, CMP, lipid panel) before week 0 and again at week 12 (Hi-Precision in Makati or BGC, USD 80–120 per panel).
Primary literature on the stack
Our partner and supplier
Primara Labs, our partner and supplier, lists every vial this protocol calls for: GHK-Cu 50mg at PHP 1,325, BPC-157 20mg at PHP 2,650, and TB-500 10mg at PHP 2,650 for the optional add-on, plus bacteriostatic water 30ml at PHP 270. Stock is held inside the Philippines: Metro Manila same day, one to three business days nationwide, 10% off every order.
View the Primara Labs catalogue